Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis

Abstract

Human tongue cancer (TC) is an aggressive malignancy with a very poor prognosis. There is an urgent need to elucidate the underlying molecular mechanisms involved in TC progression. mRNA expression profiles play a vital role in the exploration of cancer-related genes. Therefore, the purpose of our study was to identify the progression associated candidate genes of TC by bioinformatics analysis. Five microarray datasets of TC samples were downloaded from the Gene Expression Omnibus (GEO) database and the data of 133 TC patients were screened from The Cancer Genome Atlas (TCGA) head and neck squamous cell carcinoma (HNSC) database. The integrated analysis of five microarray datasets and the RNA sequencing data of TC samples in TCGA-HNSC was performed to obtain 1023 overlapping differentially expressed genes (DEGs) in TC and adjacent normal tissue (ANT) samples. Next, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was conducted to enrich the significant pathways of the 1023 DEGs and PI3KAkt signaling pathway (P=0.011) was selected to be the candidate pathway. A total of 23 DEGs with |log2 fold change (FC)| ≥1.0 in phosphatidylinositol 3-kinase-serine/threonine kinase (PI3K-Akt) signaling pathway were subjected to survival analysis of 125 eligible TC samples in TCGA database, indicating increased integrin-α3 gene (ITGA3) expression was significantly associated with poorer prognosis. Taken together, our study suggested ITGA3 may facilitate the development of TC via activating PI3K-Akt signaling pathway.

Keywords

integrin-аЗ gene / tongue cancer / Gene Expression Omnibus database / The Cancer Genome Atlas / bioinformatics analysis

References

[1] SiegelRL, MillerKD, JemalA. Cancer statistics, 2016. CA Cancer J Clin, 2016, 66(1): 7-30

[2] KokemuellerH, RanaM, RublackJ, et al.. The Hannover experience: Suigical treatment of tongue cancer--A clinical retrospective evaluation over a 30 years period. Head Neck Oncol, 2011, 3(1): 27

[3] DongY, ZhaoQ, MaX, et al.. Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differtial proteomics approach. Sci Rep, 2015, 5: 12

[4] BroadbentJ, SampsonD, SabapathyS, et al.. Gene networks in skeletal muscle following endurance exercise are coexpressed in blood neutrophils and linked with blood inflammation markers. J Appl Physiol, 2017, 122(4): 752-766

[5] LiG, LiX, YangM, et al.. Prediction of biomarkers of oral squamous cell carcinoma using microarray technology. Sci Rep, 2017, 7: 42

[6] RandhawaV, AchaiyaV. Integrated network analysis and logistic regression modeling identify stagespecific genes in oral squamous cell carcinoma. BMC Med Genomics, 2015, 8(1): 39

[7] KangDD, SibilleE, KaminskiN, et al.. MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis. Nucleic Acids Res, 2011

[8] WangX, KangDD, Shi K, et al.. Ail R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection. Bioinformatics, 2012, 28(19): 2534-2536

[9] QiC, HongL, ChengZ, et al.. Identification of metastasis associated genes in colorectal cancer using metaDE and survival analysis. Oncol Lett, 2016, 11: 568-574

[10] TsengGC, GhoshD, FeingoldE. Comprehensive literature review and statistical considerations far microarray meta-analysis. Nucleic Acids Res, 2012, 40(9): 3785-3799

[11] SunM, SunT, HeZ e ál. Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis. Qncotarget, 2017, 8(41): 69 594

[12] YuG, WangL G, HanY, et al.. clusterProfiler: an R package for compaiing biological themes among gene clusters. OMICS, 2012, 16(5): 284-287

[13] LoWY, TsaiMH, TsaiY, et al.. Identification of overexpressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta, 2007, 376(1–2): 101-107

[14] CampbellID, HumphriesMJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol, 2011

[15] BendasG, BorsigL. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol, 2012, 2012: 676

[16] KoshizukaK, HanazawaT, KikkawaN, et al.. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer. Cancer Sci, 2017, 108(8): 1681-1692

[17] TangXR, WenX, HeQM, et al.. MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma. Cell Death Dis, 2017

[18] SakaguchiT, YoshinoH, YonemoriM, et al.. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer. Br J Cancer, 2017, 116(8): 1077

[19] LinharesMM, AffonsoRJJr, de Souza VianaL, et al.. Genetic and immunohistochemical expression of integrins ITGAV, ITGA6, and ITGA3 as prognostic factor for colorectal cancer: models for global and disease-free survival. PLoS One, 2015

[20] ChenJ, XuX, WangH. Expression of integrin-α 3 mRNA in meningiomas and its correlation with proliferation and invasion. J Huazhong Univ Sci Technolog Med Sci, 2009